Skip to main content
  • About
  • Affiliated Faculty
  • Women's Health Issues
  • News
    • Jacobs Institute in the News
  • Resources
  • Schiffer Fellows
  • Brandt Lecture

Home
  •  
  •  
  •  
Menu

Main navigation

  • About
  • Affiliated Faculty
  • Women's Health Issues
    • In memory of Warren Pearse
    • Call for Papers: Policy Matters articles
    • Special Collections and Supplements
    • Gibbs Leadership Prize
  • News
    • Jacobs Institute in the News
  • Resources
    • Articles and Reports
    • Commentaries, Public Comments, and Amicus Briefs
    • Scientific Integrity
    • Bridging the Divide
  • Schiffer Fellows
    • 2020 Fellows
    • 2019 Fellows
    • 2018 Fellows
    • 2017 Fellows
    • 2016 Fellows
  • Brandt Lecture

Jacobs in the News

Breadcrumb

  1. Home
  2. Jacobs in the News

July 12, 2022 - WBUR: Here and Now

Birth control pills may soon be available over the counter for the first time ever in the U.S.

Susan Wood spoke with Robin Young about the potential for an over-the-counter progestin-only pill to increase contraceptive options. She explained the difference between progestin-only pills and progestin-estrogen combination pills and why the pills should be sold without age restrictions.

July 12, 2022 - ABC News

How Plan B works and why it's not abortion

Susan Wood explained that when FDA first considered emergency contraceptive Plan B in the 1990s, its mechanism for preventing pregnancy wasn’t totally clear. Now that we know it blocks ovulation, she suggests FDA update the language on its website to be clear, given growing false claims that emergency contraception is the same as abortion.

July 11, 2022 - Washington Post

Drugmaker seeks approval for first nonprescription birth control pill in U.S.

Susan Wood applauded the prospect of an over-the-counter birth control pill and expressed a hope that FDA would approve the application promptly. She also commented, “This is not a substitute for access to abortion care in the U.S., but will provide one more tool for the toolbox for preventing unintended pregnancies and more options for family planning.”

June 24, 2022 - Reuters

Analysis: Abortion pills over the counter? Experts see big hurdles in widening U.S. access

Susan Wood spoke to Ahmed Aboulenein about prospects for medication abortion drugs becoming available over the counter: “I personally don’t see it happening in the next couple of years.”

June 7, 2022 - Kaiser Health News

Misinformation Clouds America’s Most Popular Emergency Contraception

Susan Wood explained that in order for the label of the emergency contraceptive Plan B to be updated, the manufacturer must request a label change from FDA. She told Sarah Varney a label update would be straightforward given existing human data about the drug’s mechanism of action.

May 4, 2022 - NBC News

The biggest health risks women would face if Roe v. Wade is overturned

In response to leaked draft Supreme Court opinion that overturns the constitutional right to abortion, Susan Wood explained that we don’t expect to see the kinds of “back-alley” abortions that characterized the pre-Roe v. Wade era, because medication abortion now available.

Feb 13, 2022 - The Hill

The FDA and its new commissioner must follow the science

In an op-ed for The Hill, Susan F. Wood explains that anti-abortion groups are targeting FDA commissioner nominee Dr. Robert Califf over the abortion drug mifepristone. "At this pivotal moment for the FDA, and amidst an ongoing public health emergency that already curtails access to health care, the vote for the next FDA commissioner must be based on their ability to uphold scientific decision-making," she writes.

Jan 20, 2022 - HealthLeaders Media

Employee Healthcare Worker Morale, Safety Concerns Rise without OSHA ETS Protection

Liz Borkowski explained that the Occupational Safety and Health Administration's withdrawal of its emergency temporary standard to protect workers in healthcare settings has raised concern about occupational health risks among healthcare workers, but that employers should still provide safe and healthy workplaces as required by law. 

December 2, 2021 - Fort Worth Star-Telegram

Texas law restricting access to abortion pills takes effect as 6-week ban remains

Liz Borkowski discussed a new Texas law that limits medication abortion to 7 weeks' gestation, as opposed to the 10 weeks allowed under the FDA's current label. “It seems like Texas lawmakers are thinking they know more about the science behind medication abortion than the FDA does,” she told Ciara McCarthy. “And that seems unlikely to be true.”

Pagination

  • Page 1
  • Next page ››
  • 950 New Hampshire Ave, NW,
    6th Floor
    Washington, DC 20052
  • 202) 994-0034
  • whieditor@gwu.edu

Useful Links

  • Women's Health Issues ›
  • Bridging the Divide ›
  • Scientific Integrity ›

The Jacobs Institute of Women’s Health works to improve women’s health through research, dialogue, teaching, and information dissemination. We're part of the Milken Institute School of Public Health at the George Washington University.


Read more